Human T-cell lymphotropic virus type I (HTLV-I) associated myelopathy/tropical spastic paraparesis (HAM/TSP) is the most common chronic myelopathy in Brazil. We present the case of a 53 year old man that fulfilled the diagnostic criteria for HAM/TSP but had at the magnetic resonance imaging (MRI) of the spinal cord evidences of syringohydromyelia at the C6-C7 and D2-D7 levels along with Chiari type I malformation. The clinical picture was more typical of HAM/TSP than of syringohydromyelia, which was probably asymptomatic. The present case clearly demonstrates that serology and neuroimaging should be always used together. We conclude that, specially in places where HTLV-I is endemic, every patient with a spastic paraparesis, even with a radiological picture suggestive of a structural spinal cord lesion, should have a screening test for HTLV-I. The clinical picture must dictate the final direction of the diagnosis.
As doenças por prions (proteínas, Isentas de ácido nucleic°, corn capacidade auto-replicathm) são um grupo de enfermidades cainicas, progressives e fatais do sistema nervoso, causadas por agente transmissivel com propriedades físicas, químicas e biológicas não convencionais. Essas doenças, ao contrário da maioria das enfermidades existentes, podem ser esporádicas, transmissíveis ou genéticas. As principals doenças humanas causadas por prlons ado o Kuru, a doença de Creutzfeldt-Jakob e suas variantes, a doença de GerstmannStráussler-Scheinker e a insônia familiar fatal. Neste artigo revilem-se os principals - e mais recentes - aspectos etiopatogênicos, aruitomopatológicos, clínicos e terapêuticos acerca deste Importante grupo de enfermidades neurodegenerativas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.